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The Centers for Disease Control and Prevention implemented the Pregnancy Flu Line during the 
influenza A(H1N1)pdm09 (pH1N1) pandemic and continued operation through the 2010–11 
influenza season to collect reports of intensive care unit (ICU) admissions and deaths among 
pregnant women with influenza. The system documented the severe impact of influenza on 
pregnant women during both seasons with 181 ICU/survivals and 37 deaths reported during the 
2009 fall pandemic wave and 69 ICU/survivals and 10 deaths reported in the subsequent influenza 
season (2010–11). A health department survey suggests PFL participants perceived public health 
benefits and minimum time burdens.
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Pregnant women are at increased risk for influenza-related severe illness including 
hospitalization and death [1,2,3,4]. Early data from the influenza A(H1N1)pdm09 (pH1N1) 
pandemic indicated that pregnant women were four times more likely to be hospitalized than 
the general population, and demonstrated an urgent need for ongoing, national surveillance 
for influenza in this vulnerable population [1]. In response, the Centers for Disease Control 
and Prevention (CDC) implemented the Pregnancy Flu Line (PFL) to monitor the impact of 
influenza on maternal and fetal/infant health and provide consultation to clinicians and 
health departments.
The PFL consisted of enhanced surveillance for influenza in pregnant women and a 24-hour 
phone line connecting clinicians and health departments with board-certified obstetricians 
pediatricians and nurses [4]. Early in the pH1N1 pandemic, before PFL implementation, 
states responded voluntarily to a one-time CDC request for reporting of pregnant women 
with laboratory-confirmed influenza illness with onset from April 15 – August 21, 2009; 91 
women who were admitted to intensive care units (ICUs) and survived (ICU/survivals), and 
38 deaths were reported during this time [3, 4] (Figure 1). The PFL was implemented on 
October 9, 2009 and accepted reports of pregnant women with severe illness (ICU 
admission or death) and laboratory-positive influenza during the “fall wave” of the pH1N1 
pandemic (onset from August 21, 2009 – August 10, 2010) through the 2010–11 influenza 
season (onset from August 11, 2010 – August 31, 2011) (Figure 1). PFL staff communicated 
with health departments from 54 jurisdictions to request PFL case report forms (including 
demographic and clinical data). For the 2010–11 influenza season, the American Congress 
of Obstetricians and Gynecologists (ACOG) communicated a request for physicians to 
report severely ill pregnant women with influenza to state health department contacts which 
were provided. In both seasons, health departments in states, localities, and territories used 
existing surveillance infrastructure to identify cases; surveillance methods varied from 
passive reporting of cases from physicians to health departments to more intense case 
finding for jurisdictions that participated in the population-based Influenza Hospitalization 
Surveillance Network, which conducts surveillance for laboratory-confirmed influenza-
related hospitalizations. Our objectives were to examine the characteristics of the cases 
reported to the PFL and to evaluate the PFL’s burdens and benefits for the health 
jurisdictions that participated in the system.
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Cases reported to the PFL during the fall pH1N1 pandemic wave were compared to cases 
reported during the post-pandemic 2010–11 influenza season. PFL data from both seasons 
were also compared to pediatric deaths reported to the Influenza-Associated Pediatric 
Mortality Surveillance System [5] and to influenza-positive specimens submitted to U.S. 
laboratories collaborating with the World Health Organization/National Respiratory and 
Enteric Virus Surveillance System (WHO/NREVSS)1 [6]. We used chi-square tests to 
compare frequencies and non-parametric Wilcoxon signed-rank and Kolmogorov-Smirnov 
tests to compare differences in medians, both with a two-sided alpha of 0.05.
CDC conducted an evaluation of the PFL in September, 2011 to better understand possible 
season-specific variances in reporting and to examine the impact of the PFL on health 
department personnel. We interviewed CDC-funded influenza coordinators in 52/54 
participating state, local, and territorial health departments. Coordinators were asked about 
jurisdictional recommendations/requirements for reporting of pregnant women with 
influenza, the time burden of adding PFL case-reporting to their official responsibilities, any 
programmatic changes made as a result of PFL participation, and whether they found the 
PFL 24-hour phone line beneficial.
These data were collected as part of the emergency pandemic response and were exempt 
from human subjects review.
RESULTS
More illness (181 ICU/survivals and 37 deaths) was reported to the PFL during the 2009 fall 
pandemic wave than in the subsequent influenza season (69 ICU/survivals, 10 deaths) 
(Figure 1). The proportion of deaths reported to the PFL between the two seasons (17% and 
13%, respectively) was not statistically different (p>0.05). Pregnant women reported to the 
PFL initiated antiviral treatment earlier during the fall pandemic wave compared to the 
subsequent influenza season, although this difference in antiviral timing was only 
marginally significant (median of 4 days from onset of illness vs. 5 days, respectively; 
p=0.05). Nearly all persons were infected with pH1N1 during the fall pandemic wave [6]. 
During the subsequent influenza season, three influenza viruses predominated in national 
surveillance systems, however the PFL surveillance noted proportionally more influenza 
A(H1N1) than the other systems. Influenza A(H1N1) was characterized in 26% of pediatric 
deaths as noted in the Influenza-Associated Pediatric Mortality Surveillance System, 25% of 
all influenza-positive specimens submitted through WHO/NREVSS (Figure 2) and 55% of 
the severely ill pregnant women reported to the PFL (55% of ICU/survivals and 56% of 
deaths) with subtyping available (p<0.01); unsubtyped influenza A ranged from 17–22% in 
the three groups (Figure 2).
Of the 52 influenza coordinators who were interviewed for the PFL evaluation, most 
reported that their main sources for data collection were infection control practitioners at 
1Note that WHO/NREVSS data refer to specimens and not persons.
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hospitals (48, 92%) and public health personnel at the state departments of health (39, 75%) 
or at district/local health departments (36, 69%). Fewer coordinators reported the support of 
the Influenza Hospitalization Surveillance Network (FluSurv-NET) personnel (13, 25%) or 
others such as CDC- and state-funded personnel at hospitals (18, 35%). The total time spent 
collecting information/reporting for the PFL by all persons involved was minimal, although 
the time spent was significantly greater during the pandemic (median of 8 hours/month 
[range: 0.5 to 180 hours]) than the subsequent influenza season (3 hours/month [range: 0–84 
hours], p<0.05). Reporting practices also varied by jurisdiction and influenza season. Many 
jurisdictions required reporting of both influenza-related hospitalizations and deaths in 
pregnant women during the pandemic (23, 44%) while fewer required both reports during 
the subsequent influenza season (12, 23%). Other jurisdictions had mandatory reporting of 
hospitalizations only and but accepted reports of influenza-related deaths in pregnant women 
(8 [15%] during the pandemic and 5 [10%] subsequent season, respectively), while others 
had mandatory reporting of influenza-related deaths in pregnant women but also accepted 
reports of influenza-related hospitalizations (15 [29%] vs. 5 [10%] during the pandemic and 
subsequent influenza season, respectively). All jurisdictions responded that reporting of 
either hospitalization and/or deaths among pregnant women with influenza was required 
during the pandemic. Over half of jurisdictions (28, 54%) however indicated that reports of 
influenza-related hospitalization and/or deaths among pregnant women were not required 
during the subsequent influenza season. Two jurisdictions (4%) used other reporting 
requirements during the subsequent season.
Most influenza coordinators (33, 63%) reported that they found the PFL’s 24-hour phone 
line beneficial. In addition, many jurisdictions reported making programmatic changes as a 
result of their PFL participation, such as permanently adding pregnancy status to their 
influenza case report forms or laboratory reports (24, 46%) and many (30, 58%) also 
reported that they made other changes or realized other benefits as a result of their 
participation in the PFL.
DISCUSSION
As the first national influenza surveillance system among pregnant women spanning both 
pandemic and non-pandemic influenza seasons, the PFL improved understanding of severe 
influenza in pregnancy. The PFL findings suggest that during the same influenza season, 
different influenza viruses might predominate among pregnant women than among other 
groups (Figure 2). While this finding is subject to some limitations, it suggests the 
possibility of pregnancy-related differences in influenza severity related to influenza virus 
type, as has been suggested by other studies [7,8]. One recent study found pregnant women 
with pH1N1 to be twice as likely to be hospitalized as pregnant women with seasonal 
influenza [8]. Severity differences related to specific influenza type are also biologically 
plausible for pregnant women, especially during later trimesters when decreased maternal 
lung capacity might increase risk for severe disease from influenza virus types [2], such as 
pH1N1, that target the lower pulmonary lobe [9]. Complex immunologic changes associated 
with pregnancy [2] coupled with the exposure to H1N1, a novel virus for women of 
childbearing age [10], might increase risks for both initial infection and for increased 
severity upon infection. While causal pathways are not known, these data suggest the 
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possibility of unique responses among pregnant women with influenza and the need for 
continued and detailed surveillance among this group.
Historically, CDC’s Pregnancy Mortality Surveillance System (PMSS), which collects data 
on pregnancy-related deaths from death certificates, has been used to estimate the number of 
deaths among pregnant women with influenza. PMSS data collected from 1998–2005 
showed an average of approximately five deaths per year, ranging from 2 to 14 deaths 
annually [11]. The PFL received reports of ten influenza-related deaths among pregnant 
women during the 2010–11 influenza season alone. Both estimates likely underestimate the 
true burden of influenza-related deaths in the U.S. among pregnant women in non-pandemic 
influenza seasons. The PFL data are limited by low numbers (17/52 or 33%) of states with 
mandatory reporting requirements of influenza-related deaths among pregnant women 
during the 2010–11 season. PMSS data are limited by the variation in quality and 
completeness of vital records [12]. The true number of deaths among pregnant women with 
seasonal influenza and the seasonal variation in this number are difficult to measure given 
that influenza-related death in pregnancy is not a nationally reportable condition.
These data are subject to several limitations. First, the PFL only collected information on 
severely ill pregnant women, and this group likely is not representative of all pregnant 
women. Second, under-reporting and differential reporting might underestimate differences 
when comparing pregnancy-related influenza between the two seasons. Third, the PFL was 
designed initially for H1N1 reporting during the pandemic, and reporters could have been 
differentially disposed to report pregnant women with H1N1 infection compared to 
infections with other influenza virus types despite PFL communications requesting all 
influenza cases. Fourth, influenza subtype information was missing from all three systems 
and could have influenced our estimates of the proportions of deaths and specimens by 
subtype.
Health departments noted benefits and a minimum time burden with participation in the 
PFL, and PFL data provided new information about the unique burden of influenza on 
pregnant women and their infants. These findings suggest that similar efforts for monitoring 
disease in pregnant women might be useful in future emergency response situations and 
support the inclusion of pregnancy status in routine surveillance systems that capture 
influenza-related hospitalizations or deaths.
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Number of deaths and ICU-only admissions with pregnancy and influenza reported to CDC 
by influenza onset datea
a missing onset dates for 5 ICU-admitted pregnant women reported during the pre-PFL time 
period, 14 ICU-admitted pregnant women reported to the PFL and 1 pregnant women who 
died reported to the PFL
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Influenza subtypes reported during the 2010–11 influenza seasona among severely ill 
pregnant women with influenza reported to the Pregnancy Flu Line (PFL), compared to 
subtypes among influenza pediatric deaths and WHO/NREVSS specimens
aFor PFL and pediatric deaths reported to the Influenza-Associated Pediatric Mortality 
Surveillance System, this reporting includes onset dates from August 11, 2010 through May 
21, 2011. Reporting dates differ for influenza differ for influenza-positive specimens (not 
persons) submitted to U.S. laboratories collaborating with the World Health Organization/
National Respiratory and Enteric Virus Surveillance System (WHO/NREVSS) and include 
onset dates from October 3, 2010 through May 21, 2011
bp <0.01 for Fisher’s exact test of proportion of PFL cases with influenza A (H1N1) 
compared to both pediatric deaths with influenza A (H1N1) and all ages with influenza A 
(H1N1)
cIncludes pregnant women who died or who were admitted to the intensive care unit and 
recovered
dSource: Influenza-Associated Pediatric Mortality Surveillance System (5)
eSource: U.S. laboratories collaborating with the World Health Organization/National 
Respiratory and Enteric Virus Surveillance System (WHO/NREVSS) (6); reporting dates 
are different than for the PFL and pediatric deaths as noted above
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